Anti-Human IL-6R alpha&IL6R Reference Antibody|抗人IL-6Rα/IL6R参考抗体(靶标：人IL-6受体)
- 货号：RB9THY583036
- 价格：面议
- 点击：376
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Humanized |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 1mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | sIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P08887 |
| 背景信息 | Tocilizumab (Anti-Human IL6R, Humanized Antibody) is an anti-human interleukin-6 receptor (IL-6R) neutralizing antibody, prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab (Anti-Human IL6R, Humanized Antibody) can be used for the treatment of rheumatoid arthritis. Tocilizumab is remarkablely effective for the study of severe COVID-19 (coronavirus disease). • Expression of Interleukin 6 signaling receptors in carotid atherosclerosis., PMID:33350884 • Preclinical development of CD126 CAR-T cells with broad antitumor activity., PMID:33414408 • Physiological effects of modulating the interleukin-6 axis., PMID:29982781 • Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge., PMID:33471392 • IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization., PMID:39229261 • Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism., PMID:34576053 • Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19., PMID:35634332 • M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor., PMID:36617890 • The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes., PMID:31237452 • Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses., PMID:23946454 |
| 别名 | BCD-089, 2035008-70-7 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
相关产品:
